Details for Patent: 5,492,897
✉ Email this page to a colleague
Summary for Patent: 5,492,897
Title: | Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivatives |
Abstract: | 6-Alkoxy derivatives of Ara-G, and pharmaceutically acceptable esters thereof, are described as being useful in tumor therapy. Novel pharmaceutically acceptable esters, their preparation and pharmaceutical formulations containing them are also disclosed. |
Inventor(s): | Krenitsky; Thomas A. (Chapel Hill, NC), Averett; Devron R. (Raleigh, NC), Koszalka; George W. (Chapel Hill, NC), Wolberg; Gerald (Cary, NC) |
Assignee: | Burroughs Wellcome Co. (141) (Research Triangle Park, NC) |
Application Number: | 08/224,343 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,492,897
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,492,897
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 9015914 | Jul 19, 1990 |
International Family Members for US Patent 5,492,897
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 151637 | ⤷ Try a Trial | |||
Australia | 641533 | ⤷ Try a Trial | |||
Australia | 8196091 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |